<DOC>
	<DOCNO>NCT02933827</DOCNO>
	<brief_summary>1 . To assess safety allogeneic injection expand ADSCs patient Moderate Severe Chronic Kidney Disease 2 . To assess efficacy allogeneic injection expand ADSCs patient Moderate Severe Chronic Kidney Disease</brief_summary>
	<brief_title>Adipose-derived Stem Cells ( ADSCs ) Moderate Severe Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>A patient eligible study following apply : 1 . Aged 2080 year ( inclusive ) 2 . With chronic kidney disease ( CKD ) stage 3B 4 ( eGFR 15 44 mL/min/1.73m2 ( inclusive ) ) Note : eGFR = estimate glomerular filtration rate 3 . Having provide informed consent Any patient meeting exclusion criterion exclude study participation . 1 . Ascertained hypersensitivity component use study Note : include gentamicin , DMSO , Agglutex ( heperin ) 2 . With inadequate hematologic function : absolute neutrophil count ( ANC ) &lt; 1,500/μL OR platelet &lt; 100,000/μL OR Hemoglobin &lt; 8 g/dL 3 . With inadequate hepatic function : serum bilirubin , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) alkaline phosphatase ( AKP ) &gt; 2.5 x institutional upper limit normal ( ULN ) 4 . With hemoglobin A1c ( HbA1c ) &gt; 8.0 % 5 . With serious prior ongoing medical condition ( e.g . concomitant illness cardiovascular ( e.g . New York Heart Association grade III IV ) , hepatic ( e.g . ChildPugh Class C ) , psychiatric condition , alcoholism , drug abuse ) , medical history , physical finding , ECG finding , laboratory abnormality investigator ' opinion could interfere result trial adversely affect safety patient 6 . Pregnant lactate woman premenopausal childbearing potential take reliable contraceptive method ( ) study period 7 . With body mass index ( BMI ) great equal 36 kg/m2 8 . With known history human immunodeficiency virus ( HIV ) infection type hepatitis 9 . Judged applicable study investigator difficulty followup observation 10 . With serious diseases/medical history consider investigator condition enter trial 11 . Having participate investigational study within 4 week enter study 12 . Known suspected abuse alcohol narcotic 13 . With known history cancer within past 5 year 14 . With autoimmune disease 15 . With cystic kidney disease require kidney dialysis 16 . With precancerous condition cancer within past 5 year Screening visit</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>